Abstract
Pulmonary mycobacteriosis is usually caused byMycobacterium tuberculosis orMycobacterium avium complex. There are, however, other slow-growing mycobacteria that can cause pulmonary infection.Mycobacterium kansasii, Mycobacterium malmoense, Mycobacterium xenopi, Mycobacterium szulgai andMycobacterium simiae typically infect middle-aged to elderly persons with preexisting lung disease. Differentiation of infection with these five mycobacteria from infection withMycobacterium tuberculosis, by culture and determination of the antimicrobial susceptibility pattern of the organism are important for several reasons. All five organisms are found in water and soil. They probably infect humans from environmental habitats; human-to-human spread of infection is thought not to occur. Furthermore, isolation of the organisms in culture may represent contamination of the specimen or colonization of the patient, and not necessarily an infection. Finally, although the antituberculosis drugs — isoniazid, ethambutol, rifampin and streptomycin — have been used for treatment of infection with these five organisms, there are often differences between the antimycobacterial susceptibility patterns ofMycobacterium tuberculosis and those of the non-tuberculous mycobacteria. Thus, the optimal choice of drug therapy may differ from that used for tuberculosis.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Buhler VB, Pollack A Human infection with atypical acid-fast organisms: report of two cases with pathologic findings. American Journal of Clinical Pathology 1953, 23: 363–374.
Schwabacher H A strain of mycobacterium isolated from skin lesions of a cold-blooded animal,Xenopus laevis, and its relation to atypical acid-fast bacilli occurring in man. Journal of Hygiene (Camb) 1959, 71: 57–67.
Marks J, Schwabacher H Infection due toMycobacterium xenopi. British Medical Journal 1965, 1: 32–33.
Karasseva VT, Weiszfeiler JG, Krasznay E Occurrence of atypical mycobacteria in Macacus Rhesus. Acta Microbiologica Academiae Scientiarum Hungaricae 1965, 12: 275–282.
Weiszfeiler JG Die Biologie und Variabilität des Tuberkelbakteriums und die atypischen Mycobakterien. Akademiai Kiado, Budapest, 1969, p. 227–256.
Valdivia A, Mendez JS, Font ME Mycobacterium habana: probable nueva especie dentro de las micobacterias no classificadas. Boletin de Higiene y Epidemiologia (Habana) 1971, 9: 65–73.
Marks J, Jenkins PA, Tsukamura M Mycobacterium szulgai — a new pathogen. Tubercle 1972, 53: 210–214.
Schröder KH, Juhlin I Mycobacterium malmonense sp. nov. International Journal of Systematic Bacteriology 1977, 27: 241–246.
Hoffner SE, Henriques B, Petrini B, Källenius G Mycobacterium malmoense: an easily missed pathogen. Journal of Clinical Microbiology 1991, 29: 2673–2674.
Kent PA, Kubica GP Public health mycobacteriology. A guide for the level III laboratory. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Atlanta, 1985.
Kirschner P, Springer B, Vogel U, Meier A, Wrede A, Kiekenbeck M, Bange F-C, Böttger EC Genotypic identification of mycobacteria by nucleic acid sequence determination: report of a 2-year experience in a clinical laboratory. Journal of Clinical Microbiology 1993, 31: 2882–2889.
McSwiggan DA, Collins CH The isolation ofMycobacterium kansasii andMycobacterium xenopi from water systems. Tubercle 1974, 55: 291–297.
Bailey RK, Wyles S, Dingley M, Hesse F, Kent GW The isolation of high catalaseMycobacterium kansasii from tap water. American Review of Respiratory Disease 1970, 101: 430–431.
Maniar AC, Vanbuckenhout LR Mycobacterium kansasii from an environmental source. Canadian Journal of Public Health 1976, 67: 59–60.
Good RC, Snider DE Jr Isolation of nontuberculous mycobacteria in the United States, 1980. Journal of Infectious Diseases 1982, 146: 829–833.
Kubin M, Svandova E, Medek B, Chobot S, Ilsovsky Z Mycobacterium kansasii infections in an endemic area of Czechoslovakia. Tubercle 1980, 61: 207–212.
Portaels F, Denef M, Larsson L Pulmonary disease caused byMycobacterium malmoense. Comments on the possible origin of infection and methods for laboratory diagnosis. Tubercle 1991, 72: 218–222.
Katila M-L, Brander E, Jantzen E, Huttunen R, Linkosalo L Chemotypes ofMycobacterium malmoense based on glycolipid profiles. Journal of Clinical Microbiology 1991, 29: 355–358.
Banks J, Jenkins PA, Smith AP Pulmonary infection withMycobacterium malmoense — a review of treatment and response. Tubercle 1985, 66: 197–203.
Connolly MJ, Magee JG, Hendrick DJ Mycobacterium malmoense in the north-east of England. Tubercle 1985, 66: 211–217.
Leunenberger P, Aubert J-D, Beer V Mycobacterium malmoense. Respiration 1987, 51: 285–291.
Warren NG, Body BA, Silcox VA, Matthews JH Pulmonary disease due toMycobacterium malmoense. Journal of Clinical Microbiology 1984, 20: 245–247.
Henriques B, Hoffner SE, Petrini B, Juhlin I, Wåhlen P, Källenius G Infection withMycobacterium malmoense in Sweden: report of 221 cases. Clinical Infectious Diseases 1994, 18: 596–600.
Gross W, Hawkins JE, Murphy DB Mycobacterium xenopi in clinical specimens: water as a source of contamination. American Review of Respiratory Disease 1976, 113: 78.
Banks J, Hunter AM, Campbell IA, Jenkins PA, Smith AP Pulmonary infection withMycobacterium xenopi: review of treatment and response. Thorax 1984, 39: 376–382.
Maloney JM, Gregg CR, Stephens DS, Manian FA, Rimland D Infections caused byMycobacterium szulgai in humans. Reviews of Infectious Diseases 1987, 9: 1120–1126.
Portaels F, Larsson L, Smeets P Isolation of mycobacteria from healthy persons' stools. International Journal of Leprosy 1988, 56: 468–471.
Lavy A, Yoshpe-Purer Y Isolation ofMycobacterium simiae from clinical specimens in Israel. Tubercle 1992, 63: 279–285.
Contreras MA, Cheung OT, Sanders DE, Goldstein RS Pulmonary infection with nontuberculous mycobacteria. American Review of Respiratory Disease 1988, 137: 149–152.
Gale GL Atypical mycobacteria in a tuberculosis hospital. Canadian Medical Association Journal 1976, 114: 612–614.
Wolinsky E Nontuberculous mycobacteria and associated diseases. In: Kubica GP, Wayne LG (ed): The mycobacteria, a sourcebook. Marcel Dekker, New York, 1984.
Wallace Jr RJ, O'Brien R, Glassroth J, Raleigh J, Dutt A Diagnosis and treatment of disease caused by nontuberculous mycobacteria. American Review of Respiratory Disease 1990, 142: 940–953.
Pezzia W, Raleigh JW, Bailey MC, Toth EA, Silverblatt J Treatment of pulmonary disease due toMycobacterium kansasii: recent experience with rifampin. Reviews of Infectious Diseases 1981, 3: 1035–1039.
Ahn CH, Lowell JR, Ahn SA, Ahn S, Hurst GA Chemotherapy for pulmonary disease due toMycobacterium kansasii: effcacies of some individual drugs. Reviews of Infectious Diseases 1981, 3: 1028–1034.
Hjelm U, Kaustova J, Kubin M, Hoffner SE Susceptibility ofMycobacterium kansasii to ethambutol and its combination with rifamycins, ciprofloxacin and isoniazid. European Journal of Clinical Microbiology and Infectious Diseases 1992, 11: 51–54.
Wallace Jr RJ, Dunbar D, Brown BA, Onyi G, Dunlap R, Ahn CH, Murphy DT Rifampin-resistantMycobacterium kansasii. Clinical Infectious Diseases 1994, 18: 736–743.
Hoffner SE, Hjelm U, Källenius G Susceptibility ofMycobacterium malmoense to antibacterial drugs and drug combinations. Antimicrobial Agents and Chemotherapy 1993, 37: 1285–1288.
Hoffner SE, Hjelm U Increased growth ofMycobacterium malmoense in vitro in the presence of isonizaid. European Journal of Clinical Microbiology and Infectious Diseases 1991, 10: 787–788.
Costrini AM, Mahler DA, Gross WM, Hawkins JE, Yesner R, D'Esopo ND Clinical and roentgenographic features of nosocomial pulmonary disease due toMycobacterium xenopi. American Review of Respiratory Disease 1981, 123: 104–109.
Good RC, Silcox VA, Kilburn JO, Plikyatis BD Identification and drug susceptibility tests results forMycobacterium spp. Clinical Microbiology Newsletter 1985, 7: 133–136.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hoffner, S.E. Pulmonary infections caused by less frequently encountered slow-growing environmental mycobacteria. Eur. J. Clin. Microbiol. Infect. Dis. 13, 937–941 (1994). https://doi.org/10.1007/BF02111495
Issue Date:
DOI: https://doi.org/10.1007/BF02111495